HSA | FSA CARDS ARE NOW ACCEPTED

Women's Hormone & Fertility Genetics Explained

Estrogen metabolism, progesterone balance, fertility, thyroid function, and hormonal transitions across the lifespan are all shaped in part by your genetics. Variants in genes related to hormone production, receptor sensitivity, and endocrine metabolism can influence how your system functions — and what it needs most to stay in balance.

This hub contains the genetic insights from the PlexusDx Hormone & Fertility Genetic Report (women's pathways) — 85+ individual interpretations covering female hormone metabolism, reproductive health tendencies, and endocrine function. Each entry explains a specific genetic variant and connects it to practical guidance for nutrition, supplementation, and lifestyle.

For a complete picture, many customers pair genetic hormone insights with the PlexusDx Women's Hormone Blood Test or Women's Fertility Blood Test to see current biomarker levels alongside long-term genetic tendencies.

For education and wellness purposes only — not intended to diagnose or treat any condition.

Explore the Precision Hormone & Reproductive Health Genetic Test

Pregnancy | ADIPOQ (rs2241766)

Pregnancy | ADIPOQ (rs2241766)

Frequently Asked Questions

What genetic factors influence estrogen metabolism in women?

CYP19A1 (aromatase) variants affect conversion of androgens to estrogens, influencing baseline levels. CYP1B1 variants determine how estradiol is metabolized — 2-OH versus 16α-OH pathways, with the latter associated with more proliferative activity. COMT variants affect catechol estrogen clearance via methylation. These pathways collectively determine both the quantity and metabolite profile of estrogen — influencing hormone balance through the menstrual cycle, perimenopause, and hormonal health throughout life.

How does genetics influence PCOS risk and hormonal symptoms?

PCOS has a strong heritable component — estimated at 70% in twin studies. DENND1A variants are among the most replicated PCOS-associated loci. FSHR and INSR variants affect ovarian signaling and insulin resistance, a core driver of hyperandrogenism. Androgen receptor CAG repeat length influences sensitivity to elevated androgens. PCOS expression is significantly modulated by insulin sensitivity and body composition — both addressable through lifestyle intervention.

What genetic variants are most relevant to female fertility and ovarian reserve?

FSHR variants affect follicle-stimulating hormone receptor sensitivity, influencing ovarian response to hormonal signals. MTHFR variants are particularly relevant because folate metabolism affects homocysteine, neural tube development risk, and placentation quality. BMP15 and GDF9 variants are associated with diminished ovarian reserve and premature ovarian insufficiency. These predispositions inform fertility planning timelines and which nutritional interventions are most relevant to an individual's reproductive health profile.

How does genetics influence perimenopause timing and symptoms?

Perimenopause timing is substantially heritable — variants in DNA repair genes (BRCA2, CHEK2), hormone signaling genes (ESR1, FSHR), and metabolic pathway genes collectively influence ovarian aging rate. Symptom severity is influenced by ESR1 (estrogen receptor sensitivity) and COMT variants — affecting thermoregulation and neurological response to declining estrogen. Understanding these variants helps explain why perimenopausal experiences vary so dramatically between women of the same age.

What is the relationship between MTHFR variants and pregnancy outcomes?

MTHFR C677T homozygous (TT) variants reduce conversion of folic acid to active 5-MTHF — essential for neural tube closure, placental function, and DNA methylation during embryogenesis. Impaired methylation is associated in research with recurrent pregnancy loss, preeclampsia, and placental complications, though evidence varies by outcome. Women with MTHFR variants are advised to supplement with methylfolate preconceptionally and throughout pregnancy to ensure adequate bioavailable folate regardless of conversion capacity.